Brokerages Set NeoGenomics, Inc. (NASDAQ:NEO) Price Target at $20.20
NeoGenomics, Inc. (NASDAQ:NEO – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the eleven research firms that are covering the company, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold rating and nine have issued a buy rating on the company. The average 12 month price […]
NeoGenomics, Inc. (NASDAQ:NEO – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the eleven research firms that are covering the company, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold rating and nine have issued a buy rating on the company. The average 12 month price […]
